title: Deferoxamine does not increase the risk for bacteremia in hemodialysis patients.
authors: Department of Nephrology, Hôpital Universitaire Brugmann, Brussels.
authors: C
authors: C
authors: Tielemans
authors: J
authors: J
authors: Boelaert
authors: P
authors: P
authors: Vergauwe
authors: G
authors: G
authors: van Roost
authors: M
authors: M
authors: Segaert
authors: B
authors: B
authors: van Frachen
authors: C
authors: C
authors: Lenclud
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003676:Deferoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012307:Risk Factors; D018805:Sepsis / Q000209:etiology*
chemical_list: D003676:Deferoxamine